{"id":"aprindine","rwe":[],"tags":[{"label":"aprindine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Cytochrome P450 2D6","category":"target"},{"label":"CYP2D6","category":"gene"},{"label":"PSMA1","category":"gene"},{"label":"CALM1","category":"gene"},{"label":"C01BB04","category":"atc"},{"label":"Active","category":"status"},{"label":"Supraventricular arrhythmia","category":"indication"},{"label":"Ventricular arrhythmia","category":"indication"},{"label":"Anti-Arrhythmia Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Membrane Transport Modulators","category":"pharmacology"},{"label":"Sodium Channel Blockers","category":"pharmacology"},{"label":"Voltage-Gated Sodium Channel Blockers","category":"pharmacology"}],"phase":"marketed","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=APRINDINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:33:22.995397+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:33:28.666257+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=APRINDINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:33:29.463397+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104501/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:33:30.176275+00:00"}},"allNames":"fiboran","offLabel":[],"synonyms":["aprindine","aprindin","aprinidine","aprindine hydrochloride","aprindine HCl","amidonal","fiboran"],"timeline":[{"date":"1996-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"brandName":"Fiboran","ecosystem":[{"indication":"Supraventricular arrhythmia","otherDrugs":[],"globalPrevalence":null},{"indication":"Ventricular arrhythmia","otherDrugs":[{"name":"bretylium","slug":"bretylium","company":"Intl Medication"},{"name":"disopyramide","slug":"disopyramide","company":"Gd Searle Llc"},{"name":"lidocaine","slug":"lidocaine","company":"Fresenius Kabi Usa"},{"name":"mexiletine","slug":"mexiletine","company":""}],"globalPrevalence":null}],"mechanism":{"target":"Cytochrome P450 2D6","targets":[{"gene":"CYP2D6","source":"DrugCentral","target":"Cytochrome P450 2D6","protein":"Cytochrome P450 2D6"},{"gene":"PSMA1","source":"DrugCentral","target":"Proteasome subunit alpha type-1","protein":"Proteasome subunit alpha type-1"},{"gene":"CALM1","source":"DrugCentral","target":"Calmodulin","protein":"Calmodulin-1"},{"gene":"CALM2","source":"DrugCentral","target":"Calmodulin","protein":"Calmodulin-2"},{"gene":"CALM3","source":"DrugCentral","target":"Calmodulin","protein":"Calmodulin-3"},{"gene":"HCN4","source":"DrugCentral","target":"Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4","protein":"Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4"},{"gene":"SLC8A1","source":"DrugCentral","target":"Sodium/calcium exchanger 1","protein":"Sodium/calcium exchanger 1"},{"gene":"KCNH2","source":"DrugCentral","target":"Potassium voltage-gated channel subfamily H member 2","protein":"Potassium voltage-gated channel subfamily H member 2"},{"gene":"SCN5A","source":"DrugCentral","target":"Sodium channel protein type 5 subunit alpha","protein":"Sodium channel protein type 5 subunit alpha"}],"modality":"Small Molecule","drugClass":"aprindine","explanation":"","oneSentence":"","technicalDetail":"Aprindine is a competitive inhibitor of the Cytochrome P450 2D6 enzyme, which is a member of the cytochrome P450 family of enzymes involved in the metabolism of various medications."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/231","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=APRINDINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:44:40.716549","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:33:32.236853+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"lidocaine","drugSlug":"lidocaine","fdaApproval":"1948-11-19","patentExpiry":"May 10, 2031","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"mexiletine","drugSlug":"mexiletine","fdaApproval":"1985-12-30","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"tocainide","drugSlug":"tocainide","fdaApproval":"1984-11-09","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"aprindine","indications":{"approved":[{"name":"Supraventricular arrhythmia","source":"DrugCentral","snomedId":72654001,"regulator":"FDA"},{"name":"Ventricular arrhythmia","source":"DrugCentral","snomedId":44103008,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"lidocaine","brandName":"lidocaine","genericName":"lidocaine","approvalYear":"1948","relationship":"same-class"},{"drugId":"mexiletine","brandName":"mexiletine","genericName":"mexiletine","approvalYear":"1985","relationship":"same-class"},{"drugId":"tocainide","brandName":"tocainide","genericName":"tocainide","approvalYear":"1984","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000167348","NDDF":"005233","UNII":"5Y48085P9Q","CHEBI":"CHEBI:135370","INN_ID":"3179","RXNORM":"1054","UMLSCUI":"C0003639","chemblId":"CHEMBL2104501","ChEMBL_ID":"CHEMBL1213033","KEGG_DRUG":"D01326","DRUGBANK_ID":"DB01429","PUBCHEM_CID":"2218","SECONDARY_CAS_RN":"33237-74-0","MESH_DESCRIPTOR_UI":"D001073"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"85%"},"publicationCount":316,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"C01BB04","allCodes":["C01BB04"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:33:32.236853+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}